1. P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY. (23rd June 2022) Authors: Derigs, P.; Bethge, W.; Holtick, U.; von Tresckow, B.; Ayuk, F.; Penack, O.; Vucinic, V.; von Bonin, M.; Baldus, C.; Mougiakakos, D.; Wulf, G.; Schnetzke, U.; Stelljes, M.; Thomas, S.; Schroers, R.; Kroeger, N.; Dreger, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL. (23rd June 2022) Authors: Rejeski, K.; Albanyan, O.; Iacoboni, G.; Bücklein, V.; Blumenberg, V.; Penack, O.; Bethge, W.; Völkl, S.; Perez, A.; Carpio, C.; Schmidt, C.; Müller, N.; Reid, K.; Faramand, R.; Davila, M.; Bullinger, L.; Locke, F.; von Bergwelt-Baildon, M.; Mackensen, A.; Barba, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. (23rd June 2022) Authors: Tilmont, R.; Yakoub-Agha, I.; Eikema, D.-J.; Zinger, N.; Haenel, M.; Schaap, N.; Herrera Arroyo, C.; Schuermans, C.; Bethge, W.; Engelhardt, M.; Kuball, J.; Michieli, M.; Schub, N.; Wilson, K. M. O.; Bourhis, J. H.; Mateos, M. V.; Robin, N.; Jost, E.; Kröger, N.; Moraleda, J. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗